Obstetrics & Gynecology · Augusta, GA
NPI
1013022029
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1348 Walton Way, Ste 4100
Augusta, GA, 30901
Phone (706) 722-1381
Groups this clinician bills Medicare through
Medicare paid, 2024
$159K
3,872 services
Medicare patients, 2024
602
Average age 72
Drug cost, 2024
$145K
2,272 prescriptions
Company payments, 2025
$686
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by C K Chance was code G0328 (colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous), 484 times for 484 patients. In total C K Chance billed 3,872 services in 45 codes, and Medicare paid $159K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-20.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 484 | 484 | $17.65 | $8,544 |
| 77063 Mammography | Office | 399 | 399 | $47.84 | $19K |
| 77067 Mammography | Office | 399 | 399 | $114.24 | $46K |
| 99213 Office E&M - Established | Office | 317 | 288 | $55.69 | $18K |
| 99214 Office E&M - Established | Office | 288 | 278 | $87.56 | $25K |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 240 | 240 | $36.56 | $8,774 |
| 85018 Blood Count | Office | 240 | 237 | $2.30 | $553 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 233 | 233 | $40.04 | $9,330 |
| 77080 Standard X-ray | Office | 229 | 229 | $34.90 | $7,992 |
| 99459 Office/Outpatient Services | Office | 133 | 132 | $15.13 | $2,013 |
| 96372 Injection Administration | Office | 111 | 14 | $9.44 | $1,048 |
| 76641 Ultrasound - Nonspecific | Office | 58 | 58 | $91.06 | $5,281 |
| 99203 Office E&M - New | Office | 22 | 22 | $50.13 | $1,103 |
| 76830 Ultrasound - Abdomen and Pelvis | Office | 22 | 20 | $70.20 | $1,544 |
By year: 2022 $125K for 3,615 services; 2023 $148K for 3,481 services; 2024 $159K for 3,872 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 484 | 484 | $17.65 | $8,544 |
| 85018 Blood Count | 240 | 237 | $2.30 | $553 |
Medicare prescription drug claims, 2024
In 2024, the drug C K Chance prescribed most often to Medicare patients was Estradiol, with 650 prescriptions and refills. In total C K Chance wrote 2,272 Medicare prescriptions that cost $145K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 650 | 1,746 | 223 | $19K |
| Medroxyprogesterone Acetate Generic | 137 | 364 | 40 | $1,110 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 95 | 210 | 39 | $2,835 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 73 | 73 | 50 | $1,281 |
| Estradiol (Once Weekly) Estradiol | 68 | 117 | 17 | $11K |
| Fluconazole Generic | 65 | 65 | 43 | $377 |
| Premarin Estrogens, Conjugated | 59 | 161 | 19 | $30K |
| Testosterone Cypionate Generic | 49 | 60 | 21 | $594 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 48 | 51 | 34 | $525 |
| Estradiol-Norethindrone Acetat Estradiol/Norethindrone Acet | 46 | 116 | 13 | $5,642 |
| Estradiol (Twice Weekly) Estradiol | 42 | 90 | 12 | $3,613 |
| Norethindrone Acetate Generic | 41 | 86 | 11 | $1,271 |
| Zolpidem Tartrate Generic | 40 | 52 | Under 11 | $282 |
| Spironolactone Generic | 40 | 120 | 13 | $512 |
| Myrbetriq Mirabegron | 36 | 48 | Under 11 | $21K |
Brand drugs: 286 claims; generic drugs: 1,986 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid C K Chance $686 ($686 in general payments such as food, travel and fees) from 8 companies. The largest payer was Astellas Pharma US Inc with $279.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.